Business Context and Reporting Period
Company: Henry Schein, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 24, 2000
Business Overview: The Company operates two reportable segments: Healthcare Distribution (dental, medical, veterinary, and international) and Technology (practice management software). As of August 3, 2000, there were 41,286,794 shares of Common Stock outstanding.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended June 24, 2000 |
Six Months Ended June 26, 1999 |
Three Months Ended June 24, 2000 |
Three Months Ended June 26, 1999 |
|---|---|---|---|---|
| Net Sales | $1,121,984 | $1,095,645 | $568,174 | $559,310 |
| Gross Profit | $351,935 | $337,467 | $182,731 | $174,050 |
| Gross Margin | 31.4% | 30.8% | 32.2% | 31.1% |
| Operating Income | $54,459 | $48,223 | $30,982 | $26,778 |
| Net Income | $27,779 | $23,250 | $16,381 | $13,337 |
| Diluted EPS | $0.67 | $0.56 | $0.39 | $0.32 |
| Cash from Operations | $65,345 | $5,259 | N/A | N/A |
| Cash & Equivalents (End) | $45,900 | $25,075 | $45,900 | $25,075 |
| Total Debt (Current + Long-term) | $323,342 | $363,624 | $323,342 | $363,624 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 2.4% ($26.4 million) for the six months ended June 24, 2000, compared to the prior year. The Healthcare Distribution segment grew 2.3%, driven by a 6.8% increase in Medical sales and a 6.0% increase in Veterinary sales. International sales decreased 2.5% primarily due to unfavorable foreign exchange rates ($18.0 million impact).
- Profitability: Net income increased 19.5% to $27.8 million. Gross profit margins improved to 31.4% (from 30.8%) due to favorable sales mix.
- Merger Costs: Merger and integration costs decreased significantly to $585,000 for the six months ended June 24, 2000, compared to $7.474 million in the prior year period.
- Cash Flow: Net cash provided by operating activities surged to $65.3 million from $5.3 million, driven by a $26.2 million decrease in accounts receivable and a $7.3 million decrease in inventories.
- Debt Reduction: Total debt decreased by approximately $40 million year-over-year due to repayments on revolving credit facilities and long-term debt.
Guidance, Outlook, and Risks
- Restructuring Plan: On August 1, 2000, the Company announced a restructuring plan to eliminate approximately 300 positions (5% of the workforce). The Company expects to record a one-time pre-tax charge of approximately $14.0 million ($8.4 million after-tax) in the second half of 2000.
- Capital Expenditures: The Company expects to invest more than $25.0 million in capital projects during the fiscal year ending December 30, 2000, to modernize facilities and infrastructure.
- Legal Proceedings: The Company is a defendant in approximately 72 product liability cases, including 58 involving latex glove allergies and 9 involving "Phen/fen" drugs. The Company expects indemnification from manufacturers but notes no assurance of coverage sufficiency. A class action lawsuit regarding practice management software (Easy Dental) is pending appeal.
- Market Risks: Key risks include foreign currency fluctuations (Euro conversion), consolidation of healthcare practitioners, healthcare reform, and the rapid evolution of e-commerce.
Investor Verification Checklist
- Restructuring Impact: Verify the timing and magnitude of the $14.0 million restructuring charge expected in the second half of 2000.
- International Currency Exposure: Assess the sensitivity of future earnings to foreign exchange rates, given the $18.0 million negative impact in the first six months of 2000.
- Legal Contingencies: Monitor the status of the latex glove and "Phen/fen" liability cases and the outcome of the Easy Dental class action appeal.
- Debt Covenants: Review the terms of the $150.0 million revolving credit facility and the $230.0 million in Senior Notes to ensure compliance with covenants amidst restructuring costs.
- Acquisition Integration: Evaluate the integration progress of the three acquisitions completed in the first six months of 2000.